VersaCross™ Dedicated RF Transseptal Technology скачать в хорошем качестве

VersaCross™ Dedicated RF Transseptal Technology

The VersaCross™ RF Transseptal Platform includes an insulated RF Wire, reinforced shapeable dilator, and dedicated RFP-100A RF Puncture Generator* for predictable and efficient left heart access, with fewer and lower energy applications required to achieve successful transseptal puncture compared to electrified guidewires or needles. (1,2) Learn more at: https://bit.ly/3XZl25V Safety info: https://bit.ly/3DQ7NNn *Baylis Medical Company Radiofrequency Puncture Generator RFP-100A. Baylis Medical Company is a wholly owned subsidiary of Boston Scientific Corporation. 1 Knight BP, Wasserlauf J, Al-Dujaili S, Al-Ahmad A. Comparison of transseptal puncture using a dedicated RF wire versus a mechanical needle with and without electrification in an animal model. J Cardiovasc Electrophysiol. 2023. doi:10.1111/jce.16111 2 Wasserlauf J, Knight BP. Comparing the safety and effectiveness of dedicated radiofrequency transseptal wires to electrified metal guidewires. J Cardiovasc Electrophysiol. 2022;33(3):371-379. doi:10.1111/jce.15341 ©2025 Boston Scientific Corporation or its affiliates. All rights reserved. All trademarks are the property of their respective owners.   Prior to use, please see the complete “Directions for Use” for more information on Indications, Contraindications, Warnings, Precautions, Adverse Events, and Operator’s Instructions at www.IFU-BSCI.com. Rx only. EP-2086205-AB